HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PCPC Sets Global Priorities With Trade Group Collaboration

This article was originally published in The Rose Sheet

Executive Summary

Members from 12 cosmetic trade associations around the world attended The Personal Care Products Council’s Annual Meeting as the group shifts its focus to global collaboration on regulatory and business issues.

You may also be interested in...

Industry Faces “Flood Of Bills” In 2013, Says PCPC Exec John Hurson

At PCPC’s 119th Annual Meeting, EVP of Government Affairs John Hurson said that based on current numbers, the group could face a 45% increase in legislation with potential implications for the personal-care industry in 2013, including bills related to green chemistry and children’s product safety. PCPC is “already tracking 100 bills” this year, he said.

Cosmetic Animal-Testing Regs Tighten Around Globe, Per EU’s Example

With Europe’s full animal-testing ban for cosmetic products slated for March, activist groups are now turning up pressure on Brazil, India and China to institute or improve animal-welfare laws. As of Jan. 1, Israel has outlawed the import of cosmetics tested on animals, so that the state “possibly become[s] the world’s first cruelty-free cosmetics market,” Humane Society International notes.

PCPC Prez Westine: Educating Legislators “Critical” In 2013

In an interview with “The Rose Sheet,” Personal Care Products Council President and CEO Lezlee Westine reflects on the trade association’s accomplishments in 2012 and looks ahead to its goals for 2013.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts